Protective effect of a triazine-derivative (AA3E2) on β-amyloid-induced damages in SK-N-MC cells

Toxicology in Vitro

Volumn 23, Issue 7, 2009, Pages 1277-1283

  Yazdanparast, Razieh ^a   Shaykhalishahi, Hamed ^a  

^a UNIVERSITY OF TEHRAN   (Iran)

Author keywords

A 1 42; AA3E2; Alzheimer's disease; Apoptosis; Caspase 3; SK N MC cells

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; CASPASE 3; CATALASE; LACTATE DEHYDROGENASE; N [2 [2 (2 AMINOETHOXY)ETHOXY]ETHYL] N BUTYL 6 DECYL 1,3,5 TRIAZINE 2,4 DIAMINE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; TRIAZINE DERIVATIVE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANTIOXIDANT ACTIVITY; ARTICLE; BETA SHEET; CELL PROTECTION; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG STRUCTURE; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; OXIDATIVE STRESS;

AMYLOID BETA-PROTEIN; ANTIOXIDANTS; APOPTOSIS; CASPASE 3; CATALASE; CELL LINE, TUMOR; CELL SURVIVAL; HUMANS; OXIDATIVE STRESS; PEPTIDE FRAGMENTS; REACTIVE OXYGEN SPECIES; SUPEROXIDE DISMUTASE; TRIAZINES;

EID: 70349385343     PISSN: 08872333     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tiv.2009.07.024     Document Type: Article

References (48)

1. Adessi C., Frossard M.J., Boissard C., Fraga S., Bieler S., Ruckle T., Vilbois F., Robinson S.M., Mutter M., Banks W.A., and Soto C. Pharmacological profiles of peptide drug candidates for the treatment of Alzheimer's disease. Journal of Biological chemistry 278 (2003) 13905-13911
2. Aebi H. Catalase in vitro. Methods in Enzymology 105 (1984) 121-126
3. Aliev G., Obrenovich M.E., Reddy V.P., Shenk J.C., Moreira P.I., Nunomura A., Zhu X., Smith M.A., and Perry G. Antioxidant therapy in Alzheimer's disease: theory and practice. Mini Reviews in Medicinal Chemistry 8 (2008) 1395-1406
4. Bacskai B.J., Kajdasz S.T., McLellan M.E., Games D., Seubert P., Schenk D., and Hyman B.T. Non-Fc-mediated mechanisms are involved in clearance of amyloid-beta in vivo by immunotherapy. Journal of Neuroscience 22 (2002) 7873-7878
5. Barinaga M. Is apoptosis key in Alzheimer's disease?. Science 281 (1998) 1303-1304
6. Behl C. Amyloid beta-protein toxicity and oxidative stress in Alzheimer's disease. Cell and Tissue Research 290 (1997) 471-480
7. Behl C., and Holsboer F. Oxidative stress in the pathogenesis of Alzheimer's disease and antioxidant neuroprotection. Fortschritte der Neurologie-Psychiatrie 66 (1998) 113-121
8. Behl C., Davis J.B., Lesley R., and Schubert D. Hydrogen peroxide mediates amyloid beta protein toxicity. Cell 77 (1994) 817-827
9. Boothby L.A., and Doering P.L. Vitamin C and vitamin E for Alzheimer's disease. The Annals of Pharmacotherapy 39 (2005) 2073-2080
10. Clementi M.E., Pezzotti M., Orsini F., Sampaolese B., Mezzogori D., Grassi C., Giardina B., and Misiti F. Alzheimer's amyloid beta-peptide (1-42) induces cell death in human neuroblastoma via bax/bcl-2 ratio increase: an intriguing role for methionine 35. Biochemical and Biophysical Research Communications 342 (2006) 206-213
11. De Felice F.G., and Ferreira S.T. Beta-amyloid production, aggregation, and clearance as targets for therapy in Alzheimer's disease. Cellular and Molecular Neurobiology 22 (2002) 545-563
12. De Felice F.G., Houzel J.C., Garcia-Abreu J., Louzada Jr. P.R., Afonso R.C., Meirelles M.N., Lent R., Neto V.M., and Ferreira S.T. Inhibition of Alzheimer's disease beta-amyloid aggregation, neurotoxicity, and in vivo deposition by nitrophenols: implications for Alzheimer's therapy. FASEB Journal 15 (2001) 1297-1299
13. Dolphin G.T., Ouberai M., Dumy P., and Garcia J. Designed amyloid beta peptide fibril - a tool for high-throughput screening of fibril inhibitors. ChemMedChem 2 (2007) 1613-1623
14. Drake J., Link C.D., and Butterfield D.A. Oxidative stress precedes fibrillar deposition of Alzheimer's disease amyloid beta-peptide (1-42) in a transgenic Caenorhabditis elegans model. Neurobiology of Aging 24 (2003) 415-420
15. Findeis M.A. The role of amyloid beta peptide 42 in Alzheimer's disease. Pharmacology and Therapeutics 116 (2007) 266-286
16. Hardy J. Amyloid, the presenilins and Alzheimer's disease. Trends in Neuroscience 20 (1997) 154-159
17. Hardy J. Alzheimer's disease: the amyloid cascade hypothesis: an update and reappraisal. Journal of Alzheimer's Disease 9 (2006) 151-153
18. Hardy J.A., and Higgins G.A. Alzheimer's disease: the amyloid cascade hypothesis. Science 256 (1992) 184-185
19. Kakkar P., Das B., and Viswanathan P.N. A modified spectrophotometric assay of superoxide dismutase. Indian Journal of Biochemistry and Biophysics 21 (1984) 130-132
20. Kim W., Kim Y., Min J., Kim D.J., Chang Y.T., and Hecht M.H. A high-throughput screen for compounds that inhibit aggregation of the Alzheimer's peptide. ACS Chemical Biology 1 (2006) 461-469
21. Kirkland J.B. Lipid peroxidation, protein thiol oxidation and DNA damage in hydrogen peroxide-induced injury to endothelial cells: role of activation of poly (ADP-ribose) polymerase. Biochimica et Biophysica Acta 1092 (1991) 319-325
22. Kokkoni N., Stott K., Amijee H., Mason J.M., and Doig A.J. N-methylated peptide inhibitors of beta-amyloid aggregation and toxicity. Optimization of the inhibitor structure. Biochemistry 45 (2006) 9906-9918
23. LeBel C.P., Ischiropoulos H., and Bondy S.C. Evaluation of the probe 2′,7′-dichlorofluorescin as an indicator of reactive oxygen species formation and oxidative stress. Chemical Research in Toxicology 5 (1992) 227-231
24. Lee S., Fernandez E.J., and Good T.A. Role of aggregation conditions in structure, stability, and toxicity of intermediates in the Abeta fibril formation pathway. Protein Science 16 (2007) 723-732
25. Lorenzo A., and Yankner B.A. Beta-amyloid neurotoxicity requires fibril formation and is inhibited by Congo red. Proceedings of Natural Academy of Science USA 91 (1994) 12243-12247
26. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. The Journal of Biological Chemistry 193 (1951) 265-275
27. Marcus D.L., Thomas C., Rodriguez C., Simberkoff K., Tsai J.S., Strafaci J.A., and Freedman M.L. Increased peroxidation and reduced antioxidant enzyme activity in Alzheimer's disease. Experimental Neurology 150 (1998) 40-44
28. Masliah E., Terry R.D., Alford M., DeTeresa R., and Hansen L.A. Cortical and subcortical patterns of synaptophysinlike immunoreactivity in Alzheimer's disease. American Journal of Pathology 138 (1991) 235-246
29. McCord J.M., and Fridovich I. Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). The Journal of Biological Chemistry 244 (1969) 6049-6055
30. Milton N.G. Amyloid-beta binds catalase with high affinity and inhibits hydrogen peroxide breakdown. The Biochemical Journal 344 Pt 2 (1999) 293-296
31. Misonou H., Morishima-Kawashima M., and Ihara Y. Oxidative stress induces intracellular accumulation of amyloid beta-protein (Abeta) in human neuroblastoma cells. Biochemistry 39 (2000) 6951-6959
32. Muthuswamy A.D., Vedagiri K., Ganesan M., and Chinnakannu P. Oxidative stress-mediated macromolecular damage and dwindle in antioxidant status in aged rat brain regions: role of l-carnitine and dl-alpha-lipoic acid. Clinica Chimica Acta; International Journal of Clinical Chemistry 368 (2006) 84-92
33. Peng Q.L., Buz'Zard A.R., and Lau B.H. Pycnogenol protects neurons from amyloid-beta peptide-induced apoptosis. Brain Research 104 (2002) 55-65
34. Pillot T., Drouet B., Queille S., Labeur C., Vandekerchkhove J., Rosseneu M., Pincon-Raymond M., and Chambaz J. The nonfibrillar amyloid beta-peptide induces apoptotic neuronal cell death: involvement of its C-terminal fusogenic domain. Journal of Neurochemistry 73 (1999) 1626-1634
35. Pimplikar S.W. Reassessing the amyloid cascade hypothesis of Alzheimer's disease. The International Journal of Biochemistry and Cell Biology 41 (2008) 1261-1268
36. Saydam G., Aydin H.H., Sahin F., Selvi N., Oktem G., Terzioglu E., Buyukkececi F., and Omay S.B. Involvement of protein phosphatase 2A in interferon-alpha-2b-induced apoptosis in K562 human chronic myelogenous leukaemia cells. Leukemia Research 27 (2003) 709-717
37. 2-induced neuroblastoma cell cytotoxicity by a triazine derivative, AA3E2. European Journal of Pharmacology, in press.
38. Shimohama S. Apoptosis in Alzheimer's disease. Apoptosis 5 (2000) 9-16
39. Sorg O. Oxidative stress: a theoretical model or a biological reality?. Comptes Rendus Biologies 327 (2004) 649-662
40. Soto C. Plaque busters: strategies to inhibit amyloid formation in Alzheimer's disease. Molecular Medicine Today 5 (1999) 343-350
41. Spector D.L., Godman R.D., and Leninwand L.A. Cells: A Laboratory Manual vol. 1 (1998), Cold Spring Harbor Laboratory Press
42. Sultana R., Ravagna A., Mohmmad-Abdul H., Calabrese V., and Butterfield D.A. Ferulic acid ethyl ester protects neurons against amyloid beta- peptide (1-42)-induced oxidative stress and neurotoxicity: relationship to antioxidant activity. Journal of Neurochemistry 92 (2005) 749-758
43. Suzuki N., Cheung T.T., Cai X.D., Odaka A., Otvos Jr. L., Eckman C., Golde T.E., and Younkin S.G. An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants. Science 264 (1994) 1336-1340
44. Tamagno E., Parola M., Guglielmotto M., Santoro G., Bardini P., Marra L., Tabaton M., and Danni O. Multiple signaling events in amyloid beta-induced, oxidative stress-dependent neuronal apoptosis. Free Radical Biology and Medicine 35 (2003) 45-58
45. Terry R.D., Masliah E., Salmon D.P., Butters N., DeTeresa R., Hill R., Hansen L.A., and Katzman R. Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Annals of Neurology 30 (1991) 572-580
46. Vistica D.T., Skehan P., Scudiero D., Monks A., Pittman A., and Boyd M.R. Tetrazolium-based assays for cellular viability: a critical examination of selected parameters affecting formazan production. Cancer Research 51 (1991) 2515-2520
47. Xiao X.Q., Zhang H.Y., and Tang X.C. Huperzine A attenuates amyloid beta-peptide fragment 25-35-induced apoptosis in rat cortical neurons via inhibiting reactive oxygen species formation and caspase-3 activation. Journal of Neuroscience Research 67 (2002) 30-36
48. Zheng L., Kagedal K., Dehvari N., Benedikz E., Cowburn R., Marcusson J., and Terman A. Oxidative stress induces macroautophagy of amyloid beta-protein and ensuing apoptosis. Free Radical Biology and Medicine 246 (2009) 422-429